Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: Results from a 10-week, double-blind, placebo-controlled, dose-titration study

  • Joel M. Neutel, Vardaman Buckalew, Steven G. Chrysant, William J. Mroczek, Dennis A. Ruff, Michael Weber
  • American Heart Journal, January 1999, Elsevier
  • DOI: 10.1016/s0002-8703(99)70467-9

The authors haven't yet claimed this publication.

Read Publication